Roger Song
Stock Analyst at Jefferies
(3.17)
# 2,547
Out of 4,994 analysts
267
Total ratings
39.4%
Success rate
2.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Reiterated: Buy | $714 → $704 | $497.59 | +41.48% | 17 | Sep 9, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $125 | $36.91 | +238.66% | 19 | Sep 8, 2026 | |
| MANE Veradermics | Reiterated: Buy | $182 | $118.14 | +54.05% | 6 | Sep 8, 2026 | |
| REPL Replimune Group | Reiterated: Buy | $2 → $24 | $13.47 | +78.17% | 16 | Aug 17, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $48 | $12.79 | +275.29% | 4 | Aug 14, 2026 | |
| AVLN Avalyn Pharma | Reiterated: Buy | $52 | $32.45 | +60.25% | 2 | Aug 13, 2026 | |
| INO Inovio Pharmaceuticals | Upgraded: Buy | $1.8 → $3 | $1.29 | +132.56% | 4 | Aug 12, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $45 → $133 | $94.55 | +40.67% | 4 | Aug 11, 2026 | |
| BIOA BioAge Labs | Reiterated: Buy | $62 → $21 | $8.46 | +148.23% | 7 | Jul 31, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $101 | $40.85 | +147.25% | 12 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 | $58.11 | +42.83% | 6 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $474 | $350.88 | +35.09% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.67 | +75.30% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.50 | +214.29% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.58 | +55.04% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $71 | $78.00 | -8.97% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.71 | +484.80% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $4.35 | +313.79% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.50 | +460.00% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $2.94 | +444.22% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $42 | $13.44 | +212.50% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $154 | $68.48 | +124.88% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $60.97 | +98.46% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $11.73 | +138.70% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $7.49 | +113.62% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $40 | $16.13 | n/a | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.70 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $17 | $0.3564 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4 | $1.93 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $61.98 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $3.41 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.4801 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.72 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $145.07 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.98 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $59.02 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $2.15 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $3.33 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0002 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $33.05 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $25 | $10.83 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $4.04 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $16.44 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $33.51 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.85 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $158.13 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $1.57 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $10.50 | n/a | 1 | Apr 13, 2021 |
United Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $714 → $704
Current: $497.59
Upside: +41.48%
Structure Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $125
Current: $36.91
Upside: +238.66%
Veradermics
Sep 8, 2026
Reiterated: Buy
Price Target: $182
Current: $118.14
Upside: +54.05%
Replimune Group
Aug 17, 2026
Reiterated: Buy
Price Target: $2 → $24
Current: $13.47
Upside: +78.17%
Kailera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $12.79
Upside: +275.29%
Avalyn Pharma
Aug 13, 2026
Reiterated: Buy
Price Target: $52
Current: $32.45
Upside: +60.25%
Inovio Pharmaceuticals
Aug 12, 2026
Upgraded: Buy
Price Target: $1.8 → $3
Current: $1.29
Upside: +132.56%
Oruka Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $133
Current: $94.55
Upside: +40.67%
BioAge Labs
Jul 31, 2026
Reiterated: Buy
Price Target: $62 → $21
Current: $8.46
Upside: +148.23%
Viking Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $101
Current: $40.85
Upside: +147.25%
Jul 14, 2026
Reiterated: Buy
Price Target: $83
Current: $58.11
Upside: +42.83%
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $350.88
Upside: +35.09%
Jul 8, 2026
Reiterated: Buy
Price Target: $45
Current: $25.67
Upside: +75.30%
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.50
Upside: +214.29%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.58
Upside: +55.04%
Apr 28, 2026
Reiterated: Buy
Price Target: $58 → $71
Current: $78.00
Upside: -8.97%
Apr 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.71
Upside: +484.80%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $4.35
Upside: +313.79%
Mar 23, 2026
Reiterated: Buy
Price Target: $14
Current: $2.50
Upside: +460.00%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $2.94
Upside: +444.22%
Jan 22, 2026
Reiterated: Buy
Price Target: $13 → $42
Current: $13.44
Upside: +212.50%
Dec 19, 2025
Reiterated: Buy
Price Target: $154
Current: $68.48
Upside: +124.88%
Dec 17, 2025
Reiterated: Buy
Price Target: $121
Current: $60.97
Upside: +98.46%
Dec 10, 2025
Reiterated: Buy
Price Target: $28
Current: $11.73
Upside: +138.70%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $7.49
Upside: +113.62%
Sep 9, 2025
Reiterated: Buy
Price Target: $80 → $40
Current: $16.13
Upside: n/a
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.70
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: $9 → $17
Current: $0.3564
Upside: n/a
Aug 20, 2025
Reiterated: Buy
Price Target: $12 → $4
Current: $1.93
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $61.98
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: $28
Current: $3.41
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $10 → $8
Current: $0.4801
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $7
Current: $5.72
Upside: n/a
Apr 10, 2025
Reiterated: Buy
Price Target: $68
Current: $145.07
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.98
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $59.02
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $2.15
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $3.33
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0002
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $33.05
Upside: n/a
Oct 16, 2024
Reiterated: Buy
Price Target: $31 → $25
Current: $10.83
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $4.04
Upside: n/a
Mar 27, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $16.44
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $33.51
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $4.85
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $158.13
Upside: n/a
Apr 29, 2021
Reiterated: Buy
Price Target: $23
Current: $1.57
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $10.50
Upside: n/a